Pure Global

Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis - Trial NCT06311292

Access comprehensive clinical trial information for NCT06311292 through Pure Global AI's free database. This phase not specified trial is sponsored by Daniel J. Weiner and is currently Recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06311292
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06311292
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
Pilot Study of Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis

Study Focus

Cystic Fibrosis

Volara System

Interventional

device

Sponsor & Location

Daniel J. Weiner

University of Pittsburgh

Pittsburgh, United States of America

Timeline & Enrollment

N/A

Jun 01, 2024

Jun 01, 2025

20 participants

Primary Outcome

Sufficient sputum quantity for a pellet

Summary

This is a small pilot study with the goal of identifying a superior sputum collection method
 in Cystic Fibrosis patients unable to produce a sputum.
 
 Participants will use the Volara System during clinic visit in an attempt to produce sputum.

ICD-10 Classifications

Cystic fibrosis
Cystic fibrosis, unspecified
Cystic fibrosis with other manifestations
Cystic fibrosis with pulmonary manifestations
Cystic fibrosis with intestinal manifestations

Data Source

ClinicalTrials.gov

NCT06311292

Device Trial